Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. - Wikidata - awgldk - TriplyDB

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

http://www.wikidata.org/entity/Q33591024

about

Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions Aquaporin-4 autoimmunity Autoimmune encephalitis update Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system Histopathology and clinical course of MOG-antibody-associated encephalomyelitis Antibody biomarkers in CNS demyelinating diseases - a long and winding road Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome Autoimmune encephalopathies.Autoimmune encephalitis as differential diagnosis of infectious encephalitis.Magnetic resonance imaging and magnetic resonance spectroscopy in a young male patient with anti-N-methyl-D-aspartate receptor encephalitis and uncommon cerebellar involvement: A case report with review of the literature.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.White matter changes in childhood NMDA receptor encephalitis: Bringing new light to an old phenotype A case of inflammatory peripheral nerve destruction antedating anti-NMDA receptor encephalitis Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.Periventricular white matter lesion and incomplete MRZ reaction in a male patient with anti-N-methyl-D-aspartate receptor encephalitis presenting with dysphoric mania.Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report.MOG antibody-associated diseases Neuronal surface antibody-mediated autoimmune encephalitis.Neuroimmunology: an expanding frontier in autoimmunity.N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children Posterior cortical and white matter changes on MRI in anti-AMPA receptor antibody encephalitis NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.Heterogeneity of clinical features and corresponding antibodies in seven patients with anti-NMDA receptor encephalitis Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis Autoimmune post-herpes simplex encephalitis of adults and teenagers Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.A clinical approach to diagnosis of autoimmune encephalitis.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.A Case of Seronegative Limbic Encephalitis with Multiple Sclerosis: A Possible Overlapping Syndrome.Neuromyelitis optica spectrum disorders.

P2860

Q26741919-D0688740-355E-44F5-8F94-6ECBD26DC662 Q26799559-7B05E735-976B-487A-9628-43CC1B2522B6 Q26827114-0FA15E2D-7613-4AB1-AE15-A2B8D1035BF8 Q27006941-E050F950-706E-4D7C-8432-14A51290ACBD Q28075974-8148FF9B-423F-4265-94A9-BD2E3F54EC55 Q28259551-E82AC52E-6086-4829-9173-D7910BCAB108 Q28262403-403DF173-2709-4EDF-AEBC-A7D9E8EC85AB Q28270042-B0DEE10C-88E0-436A-A690-F3494CAE6EA7 Q29036090-0F19CCFA-F114-47DB-9455-5092D22CFBBA Q30354658-CBFCF3E8-046F-4FC6-822C-C897F1F738FA Q30371412-5B7031DC-6CCA-4828-AFA2-BD76E59B06B5 Q30389491-A0EB8190-3B87-449E-851E-AD760D294EA3 Q30813653-B613465E-1E86-4427-A1C7-D2AB448E54C8 Q31028908-98FA4D25-DAD1-40A9-8304-376AB60031C9 Q33645795-59733B6A-98EE-411C-8C01-6ACAD1F11B08 Q33862239-1010A5CE-D4C0-48C2-914A-DC43DDE2CF61 Q34368543-97E64E54-C93D-4A08-8A5D-CDADAE5E94B5 Q34368632-B4F1F721-34C5-46D3-B444-F113F8CECD9B Q34453889-D8B9D03F-01E7-432F-946B-7779E86D0BC6 Q34463760-17970201-7220-4365-86FF-5E49873F987B Q34473875-504AD55E-5909-40B4-A665-0CD73DED2465 Q34513731-86A5CE9F-D617-4D4A-9063-FFCBC340D40E Q35016115-E445C3F1-833B-4416-A1D2-1225307848BB Q35023345-E68F7706-8996-4473-A862-7A427711ABB8 Q35392781-0D5162E8-F0E6-4608-BDD3-3DFA764C430C Q35550781-06352BB2-C5F4-48B1-AC88-53E9C5776F16 Q35677766-04686984-ED35-4C52-BE02-C35A63B4CE90 Q35693056-CC2B6ECF-633B-434C-BC30-1C86F40FABB2 Q35956155-C7C2227B-59C8-43E2-8F05-EBDBB405406F Q36081031-9507CAE7-E4A8-456E-80EF-12208459AA0B Q36240987-2F37FBFF-ABCF-45FF-8355-9F52E16657A8 Q36300045-6AFF976E-7F1C-4126-9B4B-C60416638193 Q36562589-9D9B0ED8-45F3-4CA8-B916-D8A195CD6CC8 Q36778227-2DA19B6B-5A2C-4342-AC1F-EB50ECEF1D10 Q37247982-4CA0A69F-EEB5-482D-B838-707A0E8DDD47 Q37343730-990F6969-BB8B-4B90-8708-98990AFACF5F Q37374434-AB54BBFA-D62D-45E0-83E4-2FEEED45F142 Q37590294-782488C3-1147-4029-8109-06A745CC67B3 Q37606419-4B00B08E-3C96-4783-AE58-1632C5B11AAC Q38229823-31EA0359-1E1B-41DA-9184-1C923F6ADD93

P2860

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

http://www.wikidata.org/entity/Q33591024

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

@ast

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

@en

type

label

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

@ast

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

@en

prefLabel

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

@ast

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

@en

P1433

Q33591024-B90823BD-00CB-4EAC-A416-164820005A40

P1476

Q33591024-ADFD5C8B-48DD-492D-9952-5C0BCBF666AC

P2093

Q33591024-14C3027D-0C42-4F7D-ADA8-3E2882F313F0

Q33591024-2CC584A3-E901-4859-A7EB-A26C6C958F16

Q33591024-43988372-72CB-4F86-9F71-629E488A2476

Q33591024-4538828B-D778-4AE3-A833-ED737094F347

Q33591024-59B5BA88-D590-432E-9BA3-AE7BA0881F7E

Q33591024-62911C61-FD71-44C8-8A4A-D915A4ECCAD7

Q33591024-64271CEA-06DB-4B41-95D6-3016D42CD633

Q33591024-6E85BF8F-ED3A-4C0E-B9BE-AEA06B0A5E18

Q33591024-8C0D57CE-5E48-4AC9-8C1D-838BD1FF97A2

Q33591024-A16E30F5-7F76-4C93-894C-09E2BEE4D09F

P2860

Q33591024-01559759-C54E-43BF-9FCD-61D82041AA13

Q33591024-038E94A7-6CE1-4DE7-8A51-AB26277ABA2D

Q33591024-0B2D8F9E-173C-4593-BE3C-70977674D030

Q33591024-0F90F4C4-727F-420C-9454-31B252FE25D5

Q33591024-122D3242-ED10-4B01-9849-6206FF26EFF4

Q33591024-291D0259-AC9F-4B42-A2F9-E2C373A1CF50

Q33591024-35831F19-4B44-46F5-A9F2-0EBA2B3BE4F7

Q33591024-3601ECD5-D504-4619-AB18-54CB1BAA94BF

Q33591024-3CB21F77-2AAF-4E68-8290-C5A45ACA5E1B

Q33591024-404365C5-E966-44DF-A9D5-BD18F78498E5

P304

Q33591024-6462CD70-7D0F-4539-85D2-AB5B965EDF54

P31

Q33591024-C2B3A903-0259-4138-8804-CBAE5AAF94A1

P356

Q33591024-BBDAA9FC-F59B-4700-9A13-C8513ECA4C4E

P433

Q33591024-23FFF5FE-4C8C-4420-83F0-93D692BAB1DA

P478

Q33591024-50A70968-D0DA-47F9-ACB4-E2D03AF6C727

P50

Q33591024-0A2C84B4-8975-40C4-A2CC-C1DF94825F49

Q33591024-20BD8D7A-42C3-43A4-ADB1-BE3D6EE325CC

Q33591024-7A2343AE-117C-4A98-80EE-92C6BE970865

Q33591024-895FB911-5D85-4972-90EE-EF424AF29C32

Q33591024-B75A3A76-CAB9-4C18-AE62-C594769A1852

Q33591024-B8DA5284-3A26-46A9-B021-C4AF21A58539

P577

Q33591024-C8E07F26-98AC-4A4A-86A2-819B858ED527

P698

Q33591024-921D8746-C75D-45BC-97FF-81AEA32720A4

P932

Q33591024-11BB3429-5D97-4C46-A151-3843685B03EF

P356

P1433

Annals of Neurology

P1476

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

@en

P2093

Albert Saiz

http://www.w3.org/2001/XMLSchema#string

Frank Leypoldt

http://www.w3.org/2001/XMLSchema#string

Gagandeep Singh

http://www.w3.org/2001/XMLSchema#string

Huidy Shu

http://www.w3.org/2001/XMLSchema#string

Kenichi Kaida

http://www.w3.org/2001/XMLSchema#string

Leslie A Benson

http://www.w3.org/2001/XMLSchema#string

Lindsey McCracken

http://www.w3.org/2001/XMLSchema#string

Makito Hirano

http://www.w3.org/2001/XMLSchema#string

Pamela S Morales

http://www.w3.org/2001/XMLSchema#string

Paul W Wirtz

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

The spectrum of MOG autoantibody-associated demyelinating diseases

The spectrum of neuromyelitis optica.

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

NMDA receptor encephalitis mimicking seronegative neuromyelitis optica

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

P304

411-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24117

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Maarten J. Titulaer

Myrna Rosenfeld

Alvaro Cobo-Calvo

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24700511

http://www.w3.org/2001/XMLSchema#string

P932

4016175

http://www.w3.org/2001/XMLSchema#string